Conjunctivitis Does Not Increase With Longer Duration of Lebrikizumab Exposure in Patients With Moderate-to-Severe Atopic Dermatitis

April Armstrong; Andreas Wollenberg; Marjolein de Bruin-Weller; Peter A. Lio; Chitra R. Natalie; Fangyi Zhao; Amber Reck Atwater; Gemma Jimenez; Chia Yu Chu; Christian Vestergaard

doi:10.25251/skin.7.supp.276

Conjunctivitis Does Not Increase With Longer Duration of Lebrikizumab Exposure in Patients With Moderate-to-Severe Atopic Dermatitis

April Armstrong, Andreas Wollenberg, Marjolein de Bruin-Weller, Peter A. Lio, Chitra R. Natalie, Fangyi Zhao, Amber Reck Atwater, Gemma Jimenez, Chia Yu Chu, Christian Vestergaard

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	s276
Journal	SKIN: Journal of Cutaneous Medicine
Volume	7
Issue number	6
DOIs	https://doi.org/10.25251/skin.7.supp.276
Publication status	Published - Nov 2023

Access to Document

10.25251/skin.7.supp.276Licence: CC BY

https://skin.dermsquared.com/skin/article/view/2386Licence: CC BY

Cite this

Armstrong, A., Wollenberg, A., Bruin-Weller, M. D., Lio, P. A., Natalie, C. R., Zhao, F., Atwater, A. R., Jimenez, G., Chu, C. Y., & Vestergaard, C. (2023). Conjunctivitis Does Not Increase With Longer Duration of Lebrikizumab Exposure in Patients With Moderate-to-Severe Atopic Dermatitis. SKIN: Journal of Cutaneous Medicine, 7(6), s276. https://doi.org/10.25251/skin.7.supp.276

@article{b9d7231cb5574bd891bd93772a15ae66,

title = "Conjunctivitis Does Not Increase With Longer Duration of Lebrikizumab Exposure in Patients With Moderate-to-Severe Atopic Dermatitis",

author = "April Armstrong and Andreas Wollenberg and Bruin-Weller, {Marjolein de} and Lio, {Peter A.} and Natalie, {Chitra R.} and Fangyi Zhao and Atwater, {Amber Reck} and Gemma Jimenez and Chu, {Chia Yu} and Christian Vestergaard",

year = "2023",

month = nov,

doi = "10.25251/skin.7.supp.276",

language = "English",

volume = "7",

pages = "s276",

number = "6",

}

Armstrong, A, Wollenberg, A, Bruin-Weller, MD, Lio, PA, Natalie, CR, Zhao, F, Atwater, AR, Jimenez, G, Chu, CY & Vestergaard, C 2023, 'Conjunctivitis Does Not Increase With Longer Duration of Lebrikizumab Exposure in Patients With Moderate-to-Severe Atopic Dermatitis', SKIN: Journal of Cutaneous Medicine, vol. 7, no. 6, pp. s276. https://doi.org/10.25251/skin.7.supp.276

TY - JOUR

T1 - Conjunctivitis Does Not Increase With Longer Duration of Lebrikizumab Exposure in Patients With Moderate-to-Severe Atopic Dermatitis

AU - Armstrong, April

AU - Wollenberg, Andreas

AU - Bruin-Weller, Marjolein de

AU - Lio, Peter A.

AU - Natalie, Chitra R.

AU - Zhao, Fangyi

AU - Atwater, Amber Reck

AU - Jimenez, Gemma

AU - Chu, Chia Yu

AU - Vestergaard, Christian

PY - 2023/11

Y1 - 2023/11

UR - http://www.scopus.com/inward/record.url?scp=85177807984&partnerID=8YFLogxK

U2 - 10.25251/skin.7.supp.276

DO - 10.25251/skin.7.supp.276

M3 - Meeting Abstract

AN - SCOPUS:85177807984

VL - 7

SP - s276

JO - SKIN: Journal of Cutaneous Medicine

JF - SKIN: Journal of Cutaneous Medicine

IS - 6

ER -

Conjunctivitis Does Not Increase With Longer Duration of Lebrikizumab Exposure in Patients With Moderate-to-Severe Atopic Dermatitis

Access to Document

Other files and links

Cite this